Get the latest crypto news, updates, and reports by subscribing to our free newsletter.
Giấy phép số 4978/GP-TTĐT do Sở Thông tin và Truyền thông Hà Nội cấp ngày 14 tháng 10 năm 2019 / Giấy phép SĐ, BS GP ICP số 2107/GP-TTĐT do Sở TTTT Hà Nội cấp ngày 13/7/2022.
© 2026 Index.vn
ImmunityBio, Inc. (NasdaqGS: IBRX) investors who purchased or acquired the company’s securities between January 19, 2026 and March 24, 2026, inclusive, have until May 26, 2026 to file lead plaintiff applications in a securities class action pending in the United States District Court for the Central District of California, according to Kahn Swick & Foti, LLC (KSF).
KSF and its partner, former Louisiana Attorney General Charles C. Foti, Jr., said investors with substantial losses must petition the court by May 26, 2026 to serve as lead plaintiff. The firm also noted that investors may contact KSF Managing Partner Lewis Kahn without obligation or cost to discuss legal rights and how the case could affect potential recovery for economic loss.
The lawsuit, Douglas v. ImmunityBio, Inc., et al., No. 26-cv-03261, alleges that ImmunityBio and certain executives failed to disclose material information during the class period, in violation of federal securities laws.
KSF said that on March 24, 2026, a warning letter dated March 13, 2026 from the U.S. Food and Drug Administration to CEO Richard Adcock was made public. The letter states that a television advertisement and a podcast misrepresented Anktiva and resulted in its distribution violating the Federal Food, Drug, and Cosmetic Act.
The warning letter also said the violations are concerning from a public health perspective because the promotional communications create a misleading impression that Anktiva, described as a treatment for a certain type of bladder cancer, can cure and even prevent all cancer.
Following the news, ImmunityBio’s shares fell $1.98 per share, or 21%, to close at $7.42 per share on March 24, 2026.
KSF said investors who purchased ImmunityBio securities and wish to discuss their legal rights can contact Lewis Kahn toll-free at 1-877-515-1850 or email lewis.kahn@ksfcounsel.com, or visit ksfcounsel.com/cases/nasdaqgs-ibrx-2. To serve as lead plaintiff, a petition must be filed by May 26, 2026.

Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…